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With interest we read the recent publication by William McGee
and colleagues in which they conclude that arterial pressure-
based cardiac output (APCO) measurement is comparable to
intermittent thermodilution cardiac output (ICO) [1].
However, the Bland Altman plot of APCO versus ICO shows
a wide spread of data points with a percentage error of 42%.
These large variations could lead to a completely different
clinical management. Also, we disagree that a percentage
error less than 28% is a conservative requirement. By using
an error-gram, limits of precision of ±20% for both test and
reference method give predicted limits of agreement of
28.3% [2]. These limits should be respected when an
alternative cardiac output measurement technique is evalua-
ted because limits of precision in excess of 20% for a single
technique are not clinically acceptable.
Furthermore, the authors state that they only consider a
change in cardiac output of 30% or more clinically relevant.
This is in contrast to daily clinical practice in which cardiac
output changes of 10% to 15% are frequently used for
making decisions regarding therapy. Also, they have
calculated the change in cardiac output by dividing the delta
cardiac output by the mean value before and after the change.
In this way they have artificially decreased the relative change
in cardiac output. Subsequently, in the plot showing the
change in ICO versus the change in APCO, it can be
observed that when changes in ICO of more than 15% are
analyzed, in only 35% of the cases did the APCO also change
15% or more in the same direction. Moreover, in 45% of the
cases the APCO changed in the opposite direction!
Based on the results of this study, we think that APCO is not
accurate in measuring absolute values of cardiac output, nor
in tracking changes in cardiac output in a general intensive
care population.
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APCO = arterial pressure-based cardiac output; CCO = continuous cardiac output; ICO = intermittent thermodilution cardiac output; ICU = inten-
sive care unit.
Authors’ reply
William T McGee
Few data support the use of any therapy based on hemo-
dynamic variables to improve outcome in intensive care unit
(ICU) patients. In the recently completed FACTT trial, therapy
based on cardiac output had no impact on patient outcome
[3]. Other trials targeting cardiac output as a treatment
variable have had disappointing results [4].
In our study of ICU patients exhibiting a broad range of
physiological variability, the limits of precision for ICO are
±36% simply for consecutive measures of ICO. Our ICO
measurements are likely to reflect greater precision than
usual practice as the investigators would frequently obtain
additional (more than four) measurements in an attempt to
maximize reliability of the ICO data during the trial, selecting
the four measures in best agreement. In two trials involving
more homogeneous groups of patients precision was similar
[5,6].
A change in cardiac output of 15% or less should not prompt
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decisions on cardiac output changes of 10% to 15% likely
results in unnecessary hemodynamic manipulation of
unknown clinical impact and we would strongly discourage
this practice in the absence of other clinically relevant
information [7].
Both continuous methods (continuous cardiac output [CCO]
and APCO) track dynamic change in cardiac output utilizing
ICO as a reference in a remarkably similar fashion. Although
the absolute magnitude of cardiac output change with either
continuous measure is rarely identical to a simultaneous ICO
measurement, both continuous methods track ΔICO
acceptably well within ±30% (96% of the time for APCO and
95% of the time for CCO using this well accepted
technology). Breukers and colleagues [5] found concordance
of delta cardiac output in 75% of determinations comparing
ICO to APCO.
APCO is a promising minimally invasive technology that
offers great safety advantages over standard techniques
utilizing a pulmonary artery catheter when determination of
cardiac output is thought to be important for patient care in
the ICU.
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